BioAxone Therapeutic
Saint-laurent, Manitoba, Canada
About BioAxone Therapeutic
BioAxone Therapeutic operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling. It provides an experimental therapy for the treatment of neurological disorders. The company's product includes Cethrin for clinical trial for spinal cord injury. BioAxone Therapeutic was founded in 2000 and is based in Saint-Laurent, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $23.6M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2005)
- Website: bioaxone.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bioaxone-therapeutic-2534829 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.